Recently, several AKI biomarkers, including neutrophil gelatinase-associated lipocalin (NGAL) and L-type fatty acid-binding protein (L-FABP) have emerged for detection of renal damage earlier than that achieved with serum creatinine. The gene discussed is FABP1; the disease is acute kidney injury.